In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are intended for use in the collection, preparation, and examination of specimens taken from the human body. The categories tracked under this market are Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers and Reagents, Oncology and Reproductive Health Diagnostics. Immunochemistry analyzers are analytical laboratory equipment used to perform tests for infectious diagnostics, specific proteins and therapeutic drugs. GlobalData uses proprietary data and analytics to provide a comprehensive report on the immunochemistry analyzers devices market, including market shares of different players within the US. Buy the latest report here.

Smarter leaders trust GlobalData

In 2022, GlobalData’s Market Model methodology determined that the leading player in the immunochemistry analyzers market in the US was Danaher followed by F. Hoffmann-La Roche, Bio-Rad Laboratories, Siemens Healthineers, Abbott Laboratories, Agilent Technologies, Magellan Diagnostics, DiaSorin, Quidelortho, PerkinElmer, Quanterix, Eurofins Scientific, bioMerieux, Werfen Life Group SAU, Tecan Group, BMG Labtech, STRATEC and Hologic.

Immunochemistry analyzers are typically offered in modular increments, which can operate independently or simultaneously as a unit. Analyzers covered under this market include Chemiluminescence Analyzers, Immunofluorescence Analyzers and Enzyme Immunoassay (EIA) Analyzers. Analyzers that are used to perform chemical analysis (enzyme, electrolyte, metabolic, or urine analysis) are excluded and are covered under clinical chemistry.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the immunochemistry analyzers devices market within the US was expected to be over $600m in 2022.

For the latest complete market share analysis of immunochemistry analyzers device market in the US, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.